| View |
|
DRP-176-13
|
Multivitamins + Iron
|
Alertmax
|
|
Capsule
|
Vitamins / Mineral
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
CLIDP Conversion
|
10 July 2024
|
14 April 2028
|
| View |
|
DRP-2045-03
|
Fluconazole
|
Flucon
|
150 mg
|
Capsule
|
Antifungal
|
XL Laboratories Pvt. Ltd.
|
India
|
CLIDP
|
28 May 2021
|
23 March 2025
|
| View |
|
DRP-286-04
|
Mefenamic Acid
|
Memaray
|
500 mg
|
Capsule
|
Non-Steroidal Anti-inflammatory Drug (NSAID)
|
Flamingo Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
07 July 2024
|
02 May 2027
|
| View |
|
DRP-3016-03
|
Omeprazole
|
Omepracent 40
|
40 mg
|
Capsule
|
Proton Pump Inhibitor
|
Windlas Biotech Limited
|
India
|
CLIDP Conversion
|
11 July 2024
|
02 June 2028
|
| View |
|
DRP-3522-11
|
Cetirizine Hydrochloride
|
Erazin
|
5 mg/5 mL
|
Syrup
|
H1-Receptor Antagonist (Antihistamine)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
01 July 2024
|
01 February 2027
|
| View |
|
DRP-4507-08
|
Celecoxib
|
Maedicoxib
|
200 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
LifeSquare Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
12 July 2024
|
04 October 2026
|
| View |
|
DRP-4762-10
|
Telmisartan
|
Zermisar
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
08 July 2024
|
30 September 2028
|
| View |
|
DRP-4765-09
|
Telmisartan
|
Zermisar
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Scott-Edil Pharmacia Ltd.
|
India
|
CLIDP Conversion
|
08 July 2024
|
30 September 2028
|
| View |
|
DRP-4771-09
|
Co-Amoxiclav
|
Coxatech 625
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin)
|
Giyaan Pharma Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 July 2024
|
02 October 2028
|
| View |
|
DRP-4778-09
|
Amlodipine (as besilate)
|
None
|
5 mg
|
Tablet
|
Calcium Channel Blocker
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 July 2024
|
08 October 2028
|
| View |
|
DRP-4939-01
|
Cefuroxime (as Axetil)
|
Cefufer
|
125 mg/ 5 mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
PharmEvo (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
12 July 2024
|
19 November 2028
|
| View |
|
DRP-5087-08
|
Racecadotril
|
Racedril
|
30 mg / sachet
|
Powder for Oral Suspension
|
Anti-diarrheal
|
XL Laboratories Pvt. Ltd.
|
Philippines
|
CLIDP Conversion
|
08 July 2024
|
11 February 2029
|
| View |
|
DRP-5313-03
|
Hydrochlorothiazide
|
Hydromel
|
50 mg
|
Tablet
|
Diuretic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
10 July 2024
|
09 May 2029
|
| View |
|
DRP-5362-28
|
Acetylcysteine
|
None
|
600 mg
|
Powder for Oral Solution
|
Mucolytic
|
Unicure Remedies Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 July 2024
|
25 June 2029
|
| View |
|
DRP-5421-01
|
Telmisartan
|
Mistel
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Healer's Lab. Unit II
|
India
|
CLIDP Conversion
|
01 July 2024
|
05 August 2029
|
| View |
|
DRP-6051-21
|
Ketoanalogues + Essential Amino Acids
|
Ketoanalogues + Essential Amino Acids
|
Quidney Vit
|
(See Reverse for Unit Dose Formulation)
|
Renal Nutrition Therapy
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
12 July 2024
|
13 March 2030
|
| View |
|
DRP-6220-01
|
Omeprazole + Sodium bicarbonate
|
Omifer
|
20 mg/1.680 g
|
Powder for Oral Suspension
|
Proton Pump Inhibitor
|
PharmaEvo (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
12 July 2024
|
11 August 2025
|
| View |
|
DRP-6422-17
|
Omeprazole (as Sodium)
|
Omenix
|
40 mg
|
Lyophilized Powder for Injection (I.V.)
|
Proton Pump Inhibitor
|
Drug International Ltd
|
Bangladesh
|
CLIDP Conversion
|
07 July 2024
|
17 June 2025
|
| View |
|
DRP-6635-0
|
Pantoprazole (as sodium)
|
Pantoxac
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Brawn Laboratories Limited
|
India
|
CLIDP Conversion
|
01 July 2024
|
08 April 2026
|
| View |
|
DRP-7114-02
|
Rosuvastatin (as calcium)
|
None
|
10 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
J.M. Tolmann Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
01 July 2024
|
11 May 2025
|